Please login to the form below

Not currently logged in
Email:
Password:

Biogen appoints executive VP, corporate development

Daniel Karp will also become a member of the executive committee

Daniel KarpBiogen has appointed Daniel Karp as its executive vice president, corporate development effective 11 June.

Karp’s new role will see him lead the newly created corporate development function, which will include corporate and business development and corporate strategy.

He will also become a member of the executive committee and will report directly to chief executive officer Michel Vounatsos, who said: “We are very pleased to welcome Daniel to Biogen as we continue our journey as pioneers in neuroscience.

“Daniel's solid experience from Pfizer combined with his scientific and business education will serve him well in this exciting position as we aim to further build our pipeline and portfolio to tackle unmet needs in neurological diseases.”

Daniel joins Biogen from Pfizer where he most recently was Vice President, Worldwide Business Development and head of business development for R&D.  In that role, he led a global team responsible for early science transactions, partnerships and acquisitions across Pfizer's research portfolio.

He said: “It's a privilege to join Biogen, a true leader in neuroscience," Karp said.  "I'm excited to work with Biogen's innovative and talented team as we work to expand the company's portfolio of therapies for people living with serious neurodegenerative diseases.”

11th June 2018

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

Menopause-thumbnail.png
Breaking the silence: It’s time to talk about the menopause
Using findings from our latest opinion poll, Vicki Newlove outlines why the hidden landscape of menopause may finally be starting to change....
Committing time to making meaningful connections - top 5 tips
Read the second blog of the series looking at key barriers to effective patient engagement in pharma...
News:
Senior Analytics Specialist joins Research Partnership...